Literature DB >> 25779748

Lessons from 150 years of UK maternal hemorrhage deaths.

Robert Stuart Kerr1, Andrew David Weeks2.   

Abstract

We have reviewed maternal hemorrhage death rates in the UK over the past 150 years in order to draw lessons from this material for current attempts to reduce global maternal mortality. Mortality rates from data in the UK Annual Reports from the Registrar General were entered into a database. Charts were created to display trends in hemorrhage mortality, allowing comparison with historical medical advances. Hemorrhage death rates fell steadily before the 1930s; between 1874 and 1926 they fell by 56%. In contrast, there was no consistent reduction in overall maternal mortality rates until the 1930s; from 1932 to 1952 they fell by 85%, primarily due to a reduction in sepsis deaths. In conclusion the majority of maternal hemorrhage mortality reductions in the UK occurred prior to the availability of effective oxytocics, antibiotics, and blood transfusion. Improving access to and standards of maternal care is key to addressing global maternal mortality today.
© 2015 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Maternal mortality; hemorrhage; history - 19th century; history - 20th century; postpartum hemorrhage; women's health issues in developing countries

Mesh:

Year:  2015        PMID: 25779748     DOI: 10.1111/aogs.12635

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  2 in total

1.  Retained placenta: will medical treatment ever be possible?

Authors:  Achier D Akol; Andrew D Weeks
Journal:  Acta Obstet Gynecol Scand       Date:  2016-02-04       Impact factor: 3.636

2.  Women receiving massive transfusion due to postpartum hemorrhage: A comparison over time between two nationwide cohort studies.

Authors:  Paul I Ramler; Thomas van den Akker; Dacia D C A Henriquez; Joost J Zwart; Jos van Roosmalen; Jan M M van Lith; Johanna G van der Bom
Journal:  Acta Obstet Gynecol Scand       Date:  2019-02-11       Impact factor: 3.636

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.